Melatonin attenuates the effects of sub-acute administration of lead on kidneys in rats without altering the lead-induced reduction in nitric oxide

Journal of Trace Elements in Medicine and Biology

Volumn 27, Issue 4, 2013, Pages 364-369

  Martínez Alfaro, Minerva ^a   Ramírez García, Gonzalo ^a   Gutiérrez Granados, Silvia ^a   Alcaraz Contreras, Yolanda ^a   Gallegos Corona, Marco Alonso ^b   de Larrea, G Zaldivar Lelo ^b   Cárabez Trejo, Alfonso ^c  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

^c CENTRO DE FÍSICA APLICADA Y TECNOLOGÍA AVANZADA   (Mexico)

Author keywords

Lead acetate; Melatonin; Nitric oxide

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTIOXIDANT; CISPLATIN; GENTAMICIN; LEAD ACETATE; MELATONIN; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; ORGANOMETALLIC COMPOUND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; IN VITRO STUDY; KIDNEY INJURY; KIDNEY ISCHEMIA; KRUSKAL WALLIS TEST; LEAD POISONING; LYMPHOCYTE; MALE; NEPHROTOXICITY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SEPSIS; SPRAGUE DAWLEY RAT; VASODILATATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BODY WEIGHT; CHEMISTRY; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; METABOLISM; ORGAN SIZE; OXIDATION REDUCTION REACTION; PATHOLOGY; TOXICITY;

RATTUS;

ANIMALS; BODY WEIGHT; INJECTIONS, INTRAPERITONEAL; KIDNEY; MALE; MELATONIN; NITRIC OXIDE; ORGAN SIZE; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84884587029     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2013.05.003     Document Type: Article

References (39)

1. Guney M., Zagury G.J. Heavy metals in toys and low-cost jewelry: critical review of U.S. and Canadian legislations and recommendations for testing. Environ Sci Technol 2013, 46:4265-4274.
2. Coelho P., Costa S., Silva S., Walter A., Ranville J., Sousa A.C., et al. Metal(loid) levels in biological matrices from human populations exposed to mining contamination - Panasqueira Mine (Portugal). J Toxicol Environ Health A 2013, 75:893-908.
3. Soto-Jimenez M.F., Flegal A.R. Childhood lead poisoning from the smelter in Torreon, Mexico. Environ Res 2013, 111:590-596.
4. Brown M.J., Margolis S. Lead in drinking water and human blood lead levels in the United States. MMWR Surveill Summ 2013, 61(Suppl.):1-9.
5. Sabath E., Robles-Osorio M.L. Renal health and the environment: heavy metal nephrotoxicity. Nefrologia 2013, 32:279-286.
6. Boffetta P., Fontana L., Stewart P., Zaridze D., Szeszenia-Dabrowska N., Janout V., et al. Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: a case-control study from Central and Eastern Europe. Occup Environ Med 2013, 68:723-728.
7. Ilychova S.A., Zaridze D.G. Cancer mortality among female and male workers occupationally exposed to inorganic lead in the printing industry. Occup Environ Med 2013, 69:87-92.
8. Dotan Y., Lichtenberg D., Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 2004, 43:200-227.
9. Bild W., Ciobica A., Padurariu M., Bild V. The interdependence of the reactive species of oxygen, nitrogen, and carbon. J Physiol Biochem 2013, 69(1):147-154.
10. Xu W., Liu L.Z., Loizidou M., Ahmed M., Charles I.G. The role of nitric oxide in cancer. Cell Res 2002, 12:311-320.
11. Carpentieri A., Diaz de Barboza G., Areco V., Peralta Lopez M., Tolosa de Talamoni N. New perspectives in melatonin uses. Pharmacol Res 2013, 65:437-444.
12. Sliwinski T., Rozej W., Morawiec-Bajda A., Morawiec Z., Reiter R., Blasiak J. Protective action of melatonin against oxidative DNA damage: chemical inactivation versus base-excision repair. Mutat Res 2007, 634:220-227.
13. Choi S.I., Dadakhujaev S., Ryu H., Im Kim T., Kim E.K. Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. J Pineal Res 2013, 51:94-103.
14. Sainz R.M., Mayo J.C., Tan D.X., Lopez-Burillo S., Natarajan M., Reiter R.J. Antioxidant activity of melatonin in Chinese hamster ovarian cells: changes in cellular proliferation and differentiation. Biochem Biophys Res Commun 2003, 302:625-634.
15. Martinez-Alfaro M., Hernandez-Cortes D., Wrobel K., Cruz-Jimenez G., Rivera-Leyva J.C., Pina-Zentella R.M., et al. Trejo effect of melatonin administration on DNA damage and repair responses in lymphocytes of rats subchronically exposed to lead. Mutat Res 2013, 742:37-42.
16. El-Sokkary G.H., Kamel E.S., Reiter R.J. Prophylactic effect of melatonin in reducing lead-induced neurotoxicity in the rat. Cell Mol Biol Lett 2003, 8:461-470.
17. Shi D., Xiao X., Wang J., Liu L., Chen W., Fu L., et al. Melatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL1999 cells via targeting MAPK, NF-kappaB, c/EBPbeta, and p300 signaling. J Pineal Res 2013, 53:154-165.
18. Cheshchevik V.T., Lapshina E.A., Dremza I.K., Zabrodskaya S.V., Reiter R.J., Prokopchik N.I., et al. Rat liver mitochondrial damage under acute or chronic carbon tetrachloride-induced intoxication: protection by melatonin and cranberry flavonoids. Toxicol Appl Pharmacol 2013, 261:271-279.
19. Camacho M.E., Carrion M.D., Lopez-Cara L.C., Entrena A., Gallo M.A., Espinosa A., et al. Melatonin synthetic analogs as nitric oxide synthase inhibitors. Mini Rev Med Chem 2013, 12:600-617.
20. Vaziri N.D., Ding Y., Ni Z. Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension 1999, 34:558-562.
21. Collins A.R., Duthie S.J., Dobson V.L. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 1993, 14:1733-1735.
22. Ibrahim N.M., Eweis E.A., el-Beltagi H.S., Abdel-Mobdy Y.E. The effect of lead acetate toxicity on experimental male albino rat. Biol Trace Elem Res 2013, 144:1120-1132.
23. El-Missiry M.A. Prophylactic effect of melatonin on lead-induced inhibition of heme biosynthesis and deterioration of antioxidant systems in male rats. J Biochem Mol Toxicol 2000, 14:57-62.
24. Ozsoy S.Y., Ozsoy B., Ozyildiz Z., Aytekin I. Protective effect of l-carnitine on experimental lead toxicity in rats: a clinical, histopathological and immunohistochemical study. Biotech Histochem 2013, 86:436-443.
25. Inkielewicz-Stepniak I., Knap N. Effect of exposure to fluoride and acetaminophen on oxidative/nitrosative status of liver and kidney in male and female rats. Pharmacol Rep 2013, 64:902-911.
26. Lanzetti M., da Costa C.A., Nesi R.T., Barroso M.V., Martins V., Victoni T., et al. Oxidative stress and nitrosative stress are involved in different stages of proteolytic pulmonary emphysema. Free Radic Biol Med 2012, 53(1):1993-2001.
27. Mukhopadhyay P., Rajesh M., Batkai S., Kashiwaya Y., Hasko G., Liaudet L., et al. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 2009, 296:H1466-H1483.
28. Chirino Y.I., Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 2009, 61:223-242.
29. Seija M., Baccino C., Nin N., Sanchez-Rodriguez C., Granados R., Ferruelo A., et al. Role of peroxynitrite in sepsis-induced acute kidney injury in an experimental model of sepsis in rats. Shock 2013, 38:403-410.
30. Ersoz N., Guven A., Cayci T., Uysal B., Turk E., Oztas E., et al. Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS. Ren Fail 2009, 31:704-710.
31. Garber M.M., Heiman A.S. The in vitro effects of Pb acetate on NO production by C6 glial cells. Toxicol In Vitro 2002, 16:499-508.
32. Vaziri N.D., Ding Y., Ni Z. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther 2001, 298:679-685.
33. Dursun N., Arifoglu C., Suer C., Keskinol L. Blood pressure relationship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels. Biol Trace Elem Res 2005, 104:141-149.
34. Heydari A., Norouzzadeh A., Khoshbaten A., Asgari A., Ghasemi A., Najafi S., et al. Effects of short-term and subchronic lead poisoning on nitric oxide metabolites and vascular responsiveness in rat. Toxicol Lett 2006, 166:88-94.
35. Goligorsky M.S., Brodsky S.V., Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 2002, 61:855-861.
36. Ara C., Dirican A., Unal B., Bay Karabulut A., Piskin T. The effect of melatonin against FK506-induced renal oxidative stress in rats. Surg Innov 2011, 18:34-38.
37. Aydogdu N., Erbas H., Atmaca G., Erten O., Kaymak K. Melatonin reduces nitric oxide via increasing arginase in rhabdomyolysis-induced acute renal failure in rats. Ren Fail 2006, 28:435-440.
38. Lee I.C., Kim S.H., Lee S.M., Baek H.S., Moon C., Kim S.H., Park S.C., Kim H.C., Kim J.C. Melatonin attenuates gentamicin-induced nephrotoxicity and oxidative stress in rats. Arch Toxicol 2012, 86:1527-1536.
39. Stacchiotti A., Ricci F., Rezzani R., Li Volti G., Borsani E., Lavazza A., Bianchi R., Rodella L.F. Tubular stress proteins and nitric oxide synthase expression in rat kidney exposed to mercuric chloride and melatonin. J Histochem Cytochem 2006, 54:1149-1157.